209
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Comparative evaluation of efficacy and safety of cefotaxime-sulbactam with amoxicillin-clavulanic acid in children with lower respiratory tract infections

, MD, , MD, , MD, , MD &
Pages 2751-2757 | Published online: 20 Oct 2008

Bibliography

  • Klein M. Multicenter trial of cefpodoxime proxetil vs. amoxicillin-clavulanate in acute lower respiratory tract infections in childhood. International Study Group. Pediatr Infect Dis J 1995;14(4 Suppl):S19-22
  • Bush K. New β-lactamases in Gram-negative bacteria: diversity and impact on selection of antimicrobial therapy. Clin Infect Dis 2001;32:1085-9
  • Virk A, Steckelberg JM. Clinical aspects of antimicrobial resistance. Mayo Clin Proc 2000;75:200-14
  • Fantin B, Pangon B, Potel G, et al. Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like β-lactamase. Antimicrob Agents Chemother 1990;34:581-6
  • Prabhakaran K, Harris EB, Randhawa B. Bacterial action of ampicillin/sulbactam against intracellular mycobacteria. Int J Antimicrob Agents 1999;13:133-5
  • Hedberg M, Lindqvist L, Tuner K. Effect of β-lactamse inhibitors on beta-lactamases from anaerobic bacteria. Eur J Clin Microbial Infect Dis 1992;11:1100-4
  • Eugene BB. Current guidelines for the treatment and prevention of nosocomial infections. Drugs 1999;58:51-67
  • Young JPW, Husson JM, Bruch K. The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases. J Antimicrob Chemother 1980;6:293-300
  • Karachalios GN. Treatment of respiratory tract infections with a combination of amoxicillin and clavulanic acid. Int J Clin Pharmacol Ther Toxicol 1985;23:647-9
  • Anyanwu CH, Umeh BU. A clinical evaluation of clavulanate-potentiated amoxicillin in the management of moderate to severe respiratory tract infections. J Int Med Res 1988;16:210-5
  • Tatsis G, Veslemes M, Hadjistavrou C. Treatment of lower respiratory tract infections with amoxicillin/clavulanic acid in adults. J Int Med Res 1993;21:98-101
  • Cook RC, Zachariah J, Cree F, Harrison HE. Efficacy of twice-daily amoxicillin/clavulanate (‘Augmentin-duo’ 400/57) in mild to moderate lower respiratory tract infection in children. Br J Clin Pract 1996;50(3):125-8
  • Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918-51

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.